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Abstract
Because a strong correlation exists between the potency of general anesthetics and their ability to dissolve in oil, a
lipophilic site of action is often assumed. We show here that a lipophilic molecule may preferentially target less lipophilic
sites after interaction with a membrane takes place. Xenon, a chemically inert and structureless general anesthetic, was
129 1 4chosen as an unbiased molecular probe for assessment of its dynamic distribution. Site-selective, intermolecular Xe- H
nuclear Overhauser effects were used to measure the specific interaction between xenon and protons in different regions in a
phosphatidylcholine lipid membrane. It was evident that xenon–membrane interaction was directed toward the amphiphilic
head region, with significant involvement of interfacial water, despite xenon’s apolar and highly lipophilic nature in the gas
phase. This result may suggest the importance of amphiphilicity in association with anesthetic action.
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1. Introduction
It remains a great scientific challenge to determine
the molecular mechanisms of general anesthesia.
From practitioners to experimentalists and theorists,
the thinking has been directed to one of the two
putative target sites: the lipid portion of neuronal
w xmembranes 1–8 or the hydrophobic pockets in cer-
w xtain crucial excitable proteins 9–13 . Irrespective of
lipids or proteins, it is often assumed that the site of
action is hydrophobic in nature. This assumption is
based primarily on the key observations, made by
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w x w xMeyer 14 and Overton 15 at the turn of century,
that the potency of general anesthetics correlates
strongly with their solubility in organic solvents, such
 .as olive oil the Meyer–Overton rule . More recently,
a similarly successful correlation has been observed
w xin a lipid-free soluble protein, firefly luciferase 16 ,
supporting the idea that the hydrophobic site can be
modeled by a protein.
Deviation from the Meyer–Overton rule, however,
has been observed. For instance, in homologous se-
w x w xries of alkanols 17,18 and alkanes 19–21 , potency
increases with molecular weight until a point where
potency is suddenly and unexpectedly lost, despite
the ‘favorable’ oil solubility of the larger members.
This cutoff phenomenon was originally thought to
w xrelate to molecular size 18,22 , or to slow uptake and
 .equilibration of the larger members at the site s of
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w x w xaction 23,24 . More recent studies 19–21,25 have
revealed that some molecules, strikingly resembling
potent general anesthetics, are completely devoid of
w xanesthetic effects 21 . Neither hydrophobicity nor
pharmacokinetics can account for the difference
w x21,26 .
Determination of the cause of such discrepancy
may help to identify the sites of general anesthetic
action and thereby shed new light on the molecular
w xmechanisms of general anesthesia 21,27 . It has been
w xsuggested 21 that a site affected by both anesthetic
and nonanesthetic agents is unlikely to be relevant to
the production of anesthesia, whereas that corre-
sponding to correct physiological responses has an
increased chance to be involved in anesthesia.
However, other than their clinical effects, anesthet-
ics and nonanesthetics are undefined at the molecular
level. We contend that if a set of molecular properties
can be used to differentiate the anesthetic molecules
as a group from the nonanesthetic, then these proper-
ties must be either maintained or assumed after inter-
action with the relevant sites takes place. We further
hypothesize that such interaction may alter the prefer-
ential selection of a molecule for different molecular
target sites. To prove that such selection indeed
occurs and to examine the dynamic distribution of a
molecule in different molecular environments, inves-
tigations are needed that directly characterize specific
 .interaction between an anesthetic or a nonanesthetic
and a biological macromolecule, without limiting to
the traditional concept of solubility in a bulk phase.
We report here such an investigation using nuclear
 .magnetic resonance NMR spectroscopy. Inter-
129 1 4molecular, heteronuclear, Xe- H nuclear Over-
 .hauser effects NOE were used to measure the site-
specific interaction between xenon, a clinical general
w x  .anesthetic 28–32 , and a phosphatidylcholine PC
lipid membrane. Results from this investigation have
been presented in part in form of abstracts previously
w x33–35 .
2. Materials and methods
2.1. Sample preparation
Because they contain simultaneously lipophilic,
hydrophilic, and amphiphilic regions and can be eas-
ily quantified by NMR, liquid suspensions of
protein-free PC vesicles, containing 0–50% choles-
 .terol in molar ratio , were used as a model system in
this study. To prepare the vesicles, a procedure simi-
w xlar to that of Smith et al. 36 was used. Briefly,
 .measured amounts of dry L-a-lecithin- PC from egg
yolk purity)99%, from Avanti Polar Lipids, Al-
.  .abaster, AL and cholesterol Sigma, St Louis, MO
were dissolved separately in chloroform. The chloro-
form solutions were then mixed and dried down into
a thin film under a stream of nitrogen gas. Residual
chloroform was further removed by applying a high
vacuum for at least 4 h. The dried thin film was then
re-suspended into D O and sonicated into vesicles of2
a mean size of 100–130 nm in diameter.
The noble gas xenon Linde Specialty Gases, Som-
.erset, NJ was chosen as an ‘unbiased’ molecular
probe because it is structureless and chemically inert.
For each NMR sample, 4 ml of vesicle suspensions
were mixed vigorously with 10 ml naturally abundant
xenon gas at 1 atm inside a pair of rubber-sealed
syringes, and then rapidly injected into a gas-tight,
 .high-precision NMR tube Wilmad Glass, Buena, NJ
prefilled with naturally abundant xenon gas. To en-
sure that the final pressure inside the tube was 1 atm,
the tube was exposed to 1 atm xenon gas briefly
before the gas-tight valve was closed. The samples
were allowed to equilibrate at room temperature for
at least 2 h before NMR experiments were com-
menced.
2.2. NMR spectroscopy
All NMR experiments were conducted at 258C on
 .an Otsuka Chemagnetics CMXW-400SLI spectrom-
eter, operating at 110.967 and 401.102 MHz for
129Xe and 1H resonance, respectively. The nominal
908 pulse length for 129Xe was 16 ms. For all 129Xe
spectra, 4 scans were summed with a recycle delay of
400 s.
129 1 4The intermolecular Xe- H NOE was measured
between 129Xe and the protons in selected regions in
the model membrane, using the truncated driven NOE
1 . 129 . 129 .pulse sequence: P H -P Xe -Acq Xe -T ,t 908 Rs
1 .where P H was a single or a train of pulses appliedts
to 1H for a period t to saturate 1H magnetization. As
908 excitation pulse was then applied to 129Xe, fol-
lowed by the data acquisition of 129Xe. A recycle
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delay of T was inserted between repetitive scans toR
ensure relaxation of 129Xe and 1H magnetization. For
the non-selective NOE experiments, in which dy-
namic polarization transfer was measured from all
129 1 .protons to Xe, P H was a low-power, broadbandts
WALTZ-16 saturation pulse. In selective dynamic
polarization transfer experiments, in which only a
selected group of protons were saturated, the
WALTZ-16 pulse was replaced by a highly fre-
quency-selective, adiabatic pulse train, consisting of
low power, 90-ms, hyperbolic secant-shaped inver-
w xsion pulses 37 interleaved with 10-ms delays. The
total 1H saturation time, t , was set at seven predeter-s
mined values: t s5, 20, 40, 70, 100, 150, and 200 s,s
the order of which was randomized in the experi-
ments. To minimize any unforeseen effects of T1
relaxation, the T was also varied such that t qTR s R
scs400 s, which is about 6–8-times the T of1129  .Xe in the lipid vesicle suspension see below .
2.3. Theoretical analysis of truncated dri˝en, inter-
molecular NOE
The truncated driven NOE originates from nonco-
herent nuclear dipole-dipole cross-relaxation and can
be analyzed using the classical Solomon equations.
For one I spin and N equivalent S spins, these
equations are:
d I t .z
d t
N
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)  .where s and r s1rT are the cross-relaxation1d-d
and direct dipolar relaxation rates, respectively, the
subscripts denote the associated spins, and the super-
script 0 indicates the thermal equilibrium state.
In truncated driven NOE, S spins are saturated:
 .S t s0. For intermolecular dipole–dipole interac-zi
tion, s is governed by the intermolecular ap-ISi
proaching distance, which varies rapidly with time in
the liquid state. By defining a time-averaged intermo-
 .lecular cross-relaxation rate constant, -Ss t ) ,ISi
 .Eq. 1 can be solved to yield:
N
s IS ;i
)is10 0 yr tI sI t s I q S 1ye 3 .  .  .z s z z)rI
where t is the saturation time for S spins.s
The NOE, h, is measured as the relative changes
in the I magnetization. Specifically for this study,
Is129Xe, Ss1H, and the NOE is given by:
N
s XeyH ;ig )H is1 yr t1Xe sh t s 1ye 4 .  .  .Xe s )g rXe 1Xe
where g and g are gyromagnetic ratios of 1H andH Xe129Xe, respectively. Thus, by measuring h as aXe1  . 129function of H saturation time t , the Xe directs
 ) .dipolar relaxation rate r and the time-averaged1Xe
sum of the cross-relaxation rate constants between
129 1  .Xe and the selected H -Ss ) can beXeyH i
determined.
3. Results
129 { 1 }3.1. Non-selecti˝e Xe- H intermolecular NOE
A strong interaction exists between xenon and the
lipid membranes. For 129Xe dissolved in lipid-free
D O, we found that the T and T of 129Xe, as2 1 2
measured using the conventional inversion-recovery
and Carr–Purcell–Meiboom–Gill methods, were 122
 ."37 s mean"S.E. and 17"3 s, respectively.
These values were reduced, for example, to 60"14 s
and 248"4 ms, respectively, in sonicated PC vesicle
suspensions of 37.5 mM lipids without cholesterol,
and to 51"4 s and 23"1 ms, respectively, in
unsonicated PC suspensions of the same lipid concen-
tration. These reductions resulted primarily from nu-
clear dipole interaction between 129Xe and protons in
129 1 4the model membrane, as evidenced by the Xe- H
intermolecular NOE build-up. Fig. 1 shows a repre-
sentative series of 129Xe-NMR spectra acquired from
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Fig. 1. A series of high-resolution 129Xe-NMR spectra, acquired
at nominal clinical concentration of xenon in a liquid suspension
of phosphatidylcholine lipid vesicles, are plotted as a function of
1H saturation time, showing non-selective, truncated driven
129 1 4Xe- H intermolecular NOE.
 129 .naturally abundant xenon f26.4% Xe at 1 atm
in a D O suspension of sonicated PC vesicles 37.52
.mM lipids, no cholesterol . After non-selective satu-
ration of 1H, the 129Xe magnetization decreases as a
result of negative NOE. Note that because g rgH Xe
-0, a negative NOE suggests a positive -sXe-H i
 ..) . See Eq. 4 . The rate of this decrease, measured
as a function of the 1H saturation time, can be used to
quantify the strength of overall xenon–membrane
interaction. For this particular set of spectra, nonlin-
 .ear least-squares fit using Eq. 4 yields -s)s
y1 0.163"0.042 min and T s71"10 s mean"1d-d
.S.E. . Placement of saturation frequency outside the
1H spectral width resulted in no change in the 129Xe
spectral intensity, confirming that the observed nega-
tive NOE was not an artifact.
129 { 1 }3.2. Selecti˝e Xe- H intermolecular NOE
The truncated driven NOE from selected groups of
protons in the membrane to 129Xe allows for quantifi-
cation of specific interaction between xenon and
membrane. Our highly frequency-selective pulse train
permits selective saturation of individual peaks in the
1H spectra. Examples of excellent spectral selectivity
 .in a sample of 37.5 mM PC without cholesterol are
shown in Fig. 2a, in which the saturated protons are
marked with vertical arrows. Selectivity of the same
quality was obtained at all other PC and cholesterol
concentrations studied. It is evident from these spec-
Fig. 2. Selective saturation of a particular group of protons allows
129 1  .for investigation of site-specific Xe- H NOE buildup. a
Representative 1H-NMR spectra of PC vesicles, showing selec-
 .tive saturation of protons marked by vertical arrows in the
 .terminal methyl group -CH , the aliphatic methylene group3
 . .  .  .
-CH , the choline methyl group Cho , and the water HDO ,2 n
respectively. The top trace is a one-pulse spectrum used as a
control. Data shown are from a sample of 37.5 mM PC without
cholesterol. Selectivity is the same at all other PC and cholesterol
.  .  .concentrations studied. b Selective NOEs from -CH , Cho,2 n
and HDO to 129Xe are measured as a function of 1H saturation
time data shown are from samples of 75 mM lipids without
.cholesterol . All h values were calculated as relative changesXe
in 129Xe magnetization to its thermal equilibrium value, deter-
mined experimentally by placing the saturation pulses outside the
1  .H spectral bandwidth 1–2 MHz off-resonance . Error bars
 .show the standard deviation S.D. of multiple measurements.
 .Solid lines are best fit to the data using Eq. 4 , yielding
129 -s ) between Xe and the three groups of protons see text
.for details .
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tra that spin diffusion among different groups of
protons, a process that would degrade the selectivity,
is negligible because the intensities of unsaturated 1H
peaks are essentially unchanged. Exception to this is
the saturation of the -CH peak, which severely3
 . .overlaps with the tail of the broad -CH peak.2 n
With such selective saturation, NOE from a particular
group of protons to 129Xe can be measured based on
the resultant change in the 129Xe spectral intensity,
similar to that shown in Fig. 1, as a function of 1H
saturation time. Representative examples of such
measurements at a lipid concentration of 75 mM
without cholesterol are shown in Fig. 2b for the
 . .aliphatic methylene protons -CH , the choline2 n
 .  .methyl protons Cho , and the water protons HDO ,
respectively. The solid lines in Fig. 2b are best fit to
 .the data using Eq. 4 , yielding -s )sXe-CH2
y1  .  .0.328"0.004 min mean"S.E. , T Xe-CH1d-d 2
s43"1 s, -s )s0.158"0.009 miny1,Xe-Cho
 .T Xe-Cho s44"3 s, -s )s0.086"1d-d Xe-HDO
y1  .0.004 min , and T Xe-HDO s53"3 s, where1d-d
s , s , and s are the pairwiseXe-CH2 Xe-Cho Xe-HDO
cross-relaxation rates between 129Xe and the three
groups of protons, respectively.
3.3. Pairwise 129Xe- 1H cross-relaxation rates
The pairwise cross-relaxation rate, s , depends on
the motional characteristics of the interacting nuclei.
A variety of possibilities can be considered, ranging
from weak interaction due to translational diffusion
of xenon in the vicinity of protons, to tight binding of
xenon to protons to form a xenon-membrane com-
plex. In the former extreme, if 129Xe and 1H are
approximated by structureless spheres, then s can be
shown to be proportional to the concentration of the
protons causing the relaxation, and inversely to the
distance of closest approach and the mutual transla-
.tional self-diffusion constant of xenon and lipid
w xmolecules 38 . In the latter extreme, where the inter-
action can be viewed as intramolecular, s is propor-
tional to the correlation time of xenon-membrane
 .complex assuming extreme narrowing condition and
inversely to the sixth power of the internuclear dis-
w xtances 39 . Situations intermediate to these extremes
are likely to occur under normal experimental condi-
tions, and are often too complicated to be examined
analytically.
Fig. 3. -s ) and -s ) are plotted as aXe-Cho Xe-CH2
function of normalized 1H peak intensity when the lipid concen-
 .tration increases from 11 to 82 mM no cholesterol . Error bars
 .indicate "S.D. ns4 . The solid lines are linear least-squares fit
to the data. The linear increase in -s ) suggests that -s
) is proportional to the number of protons contributing to the
 .selective NOE. The proportionality the slope is a measure of the
mean pairwise cross-relaxation rate, -s ).
For simplicity, we assume that a mean pairwise
cross-relaxation rate, -s) , can be defined between
129Xe and 1H such that -s) is identical for all
protons in the same group. Thus, -s)sN =-k
s) , where N is the number of protons in group k.k
When the lipid concentration increases, N increasesk
proportionally and so does the NMR peak intensity
for the corresponding 1H group. Fig. 3 depicts -s
) as a function of normalized 1H intensities for Cho
 .and -CH when lipid concentration is varied from2 n
 .11 to 82 mM no cholesterol . Each point in this
figure resulted from fittings of repeated NOE mea-
surements, similar to that shown in Fig. 2b, at the
given PC concentrations. Solid lines are linear least-
squares fit to the data, yielding slopes proportional to
-s) of the two 1H groups. From Fig. 3, it is
evident that the mean pairwise cross-relaxation rate
between xenon and the Cho group in the lipid head
region is at least three times greater than that between
xenon and the aliphatic methylene group mostly in
 .the tail region i.e., -s ) :-s )G3:1 .Xe-Cho Xe-CH2
Because mean pairwise -s) reflects the closeness
and tightness of xenon–proton interaction, a larger
-s ) compared to -s ) suggests thatXe-Cho Xe-CH2
a strong xenon–membrane interaction is directed to-
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ward the amphiphilic head region of the lipids, rather
than to the lipophilic tail region.
3.4. In˝ol˝ement of interfacial water in xenon–mem-
brane interaction
The presence of lipid vesicles can enhance the
xenon–water interaction, which seems to occur at the
lipidrwater interface. In lipid-free bulk water, the
pairwise cross-relaxation between 129Xe and water
proton was negligibly weak. No NOE build-up was
measurable between 129Xe and HDO in bulk D O,2
and a summation over f28 M of water protons i.e.,
.25% H O in D O yields only a -s) of 0.0722 2
"0.012 miny1. This changed, however, when lipids
were present. We found that -s ) in-Xe-HDO
creased linearly with increasing lipid concentrations.
For lipid concentrations in the range of 11 to 82 mM
 .i.e., the same range as that shown in Fig. 3 ,
-s ) increases from 0.049 " 0.007 toXe-HDO
0.129"0.010 miny1. We believe that this increase is
related to the increase in total vesicle surface area
and therefore represents xenon–water interaction at
the lipidrwater interface. The possibility of unfore-
seen lipid saturation can be ruled out because the
T associated with -s ) is at least 20%1d-d Xe-HDO
longer than that associated with -s ) orXe-CH2
-s ) , and because selective irritation in theXe-Cho
vicinity of the water peak about"100 Hz off reso-
.nance resulted in smaller -s ) due toXe-HDO
partial HDO saturation. The latter would not be
expected if -s ) were originated from sat-Xe-HDO
uration of an NMR-invisible broad component.
129 { 1 }3.5. Effects of cholesterol on Xe- H NOE
The tendency of xenon to interact favorably with
the interfacial region of the lipid vesicle is enhanced
with increasing cholesterol concentrations. Addition
of cholesterol to the lipid bilayer caused a linear
increase in -s) , as shown in Fig. 4, but to a
different extent depending on the specific proton
groups. Thus, at a fixed PC concentration of 45.0
 .mM and for an increase from 0 to 50% molrmol in
cholesterol concentration, -s ) increasedXe-Cho
by f 120%, -s ) by f 118%, andXe-HDO
-s ) by only f20%. The increase inXe-CH2
-s ) is smaller than what would be ex-Xe-CH2
Fig. 4. Dependence of -s ) on cholesterol concentration.
 .The PC concentration was constant 45.0 mM . Error bars show
 ."S.D. ns4 . The solid lines are linear least-squares fit to the
data.
pected for the increase in the number of protons
 .attributable to cholesterol in the -CH and -CH2 n 3
regions, suggesting that cholesterol either has no
effect on the mean pairwise cross-relaxation rate in
this region, or actually reduces it. In contrast, because
no resonance from cholesterol overlaps with the Cho
peak thus the number of protons in this group is
.constant , the significant increase in -s )Xe-Cho
after addition of cholesterol is entirely due to increase
in mean pairwise -s ) i.e., stronger Xe–ChoXe-Cho
.interaction . This result is consistent with the finding
w xfrom other methods 40–43 that cholesterol rigidifies
the head region of the bilayer; a reduction in mobility
in the head region enhances the mean cross-relaxa-
tion rate -s ) . The effects of cholesterol onXe-Cho
-s ) are twofold. On the one hand, choles-Xe-HDO
terol is known to reduce the number of hydration
 w x.from 22 to 8 or 9 per lipid molecule, 43 and
therefore reduce the number of water protons inter-
acting with xenon at the interface. On the other hand,
the interfacial hydroxyl protons of the cholesterol
resonate at the same frequency as those of water and
therefore also contributes to -s ) . Al-Xe-HDO
though the loss of interfacial water protons outnum-
bers the gain of cholesterol hydroxyl protons, an
increase in -s ) by 118% strongly indi-Xe-HDO
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cates that cholesterol significantly augments
-s ) , mostly due to xenon interaction withXe-HDO
the cholesterol’s hydroxyl protons at the lipidrwater
interface. Because the cholesterol-to-lipid ratio in the
 .central nervous system is typically 40% molrmol
w x44 , xenon interaction with neuronal membranes in
vivo is likely to be directed toward the head and
interfacial region, more so than indicated in Fig. 3.
4. Discussion
The tendency for xenon to interact preferably with
the amphiphilic interface of the lipid vesicles over the
more lipophilic tail region and the more hydrophilic
aqueous region has significant implications. It not
only provides direct experimental evidence to support
the possibility of amphiphilic sites for anesthetic
action, but also explains why for many volatile anes-
thetics, the product of potency=oilrgas partition
coefficient deviates more from a constant predicted
w xby the Meyer–Overton rule 45 than does the prod-
uct of potency = oilrgas partition coefficient =
w x salinergas partition coefficient 23 . The second
product clearly implicates the importance of a polar
.component. More importantly, our results show that
the selection of molecular target sites, when many
different types are available, depends not only on the
properties of the anesthetic molecule itself, but also
on possible changes in these properties after interac-
tion with a membrane takes place. Thus, although
 .xenon is apolar with a spherical symmetry in the
gas phase and would be expected to be more compat-
ible with the core of the lipid bilayer, its choice for
the interface is clearly governed, once in the mem-
brane, by the induced dipole that makes xenon more
adaptable to an amphiphilic region. A similar but
opposite argument could be made that some
molecules, having a ‘desirable’ solubility in olive oil
to be anesthetics according to the Meyer–Overton
rule, find themselves attractable to the more lipophilic
core of the lipid after dissolving into the membrane
and henceforth become nonanesthetics. A generaliza-
tion of this would suggest that molecules that are
amphiphilic after interacting with membrane con-
stituents are anesthetics, whereas those that are either
extremely lipophilic or extremely hydrophilic are
likely to have minimal or no anesthetic effects. If this
is true, then it is not surprising that disobedience to
Meyer–Overton rule occurs.
The involvement of a polar component in anes-
thetic action has been postulated previously. Theoret-
w xically, it has been predicted 46,47 that polar interac-
tions like the breaking and formation of hydrogen
bonds are important for the mechanisms of general
anesthesia, and that the polarizability of a nonpolar
molecule may be relevant to its anesthetic effect.
Experimentally, it has been shown that anesthetic
alcohols can bind to the surface of dimyristoylphos-
 . w xphatidylcholine DPPC membranes 48,49 , release
w xwater molecules from the lipid surface 22,50,51 ,
and produce stronger effects on the pretransition tem-
perature which is believed to relate to the hy-
.drophilic head property than on the main transition
w xtemperature of a membrane 52 . In a recent two-di-
mensional 1H NOESY study using high concentration
w xof methoxyflurane in DPPC vesicles 53 , a pair of
cross peaks was detected between the choline methyl
protons of the DPPC and the methoxy protons of the
methoxyflurane. No other cross peaks were found.
w xBased on these results, it has been suggested 53 that
the probability of finding anesthetic molecules is
highest at the lipid interface.
It should be noted that our choice of PC lipids as a
model was arbitrary. Amphiphilic domains exist also
in neuronal proteins. A superfamily of neurotrans-
mitter-gated receptor channels, including the g-
aminobutyric acid type A receptor, the glycine recep-
tor, the nicotinic acetylcholine receptor, and 5-hy-
droxytryptamine type 3 receptor, are particularly sen-
w xsitive to general anesthetics 9,54 . The subunits of
these receptors have similar overall hydrophobicity
and hydrophilicity pattern that fluctuates along the
sequence between lipophilic and hydrophilic ex-
w xtremes 55 . Such fluctuation may result in residues
with amphiphilic characteristics. Therefore, a plausi-
ble mechanism of general anesthetic action is to
nonspecifically alter the amphiphilic domains in these
receptors such that association of the receptor with
the aqueous environment at the membrane interface
is changed. This change, in turn, may cause alteration
in receptor conformation or agonist affinity to the
receptor binding sites, or both.
In conclusion, a chemically and structurally unbi-
ased general anesthetic was found to interact prefer-
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entially with the amphiphilic region of a model
biomembrane.
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